EU4Health: MEPs Reach Deal with Council on 2021-2027 EU Health Programme

European CommissionThe new EU health programme, worth 5.1 billion EUR, will help to fix shortcomings exposed by COVID-19 and boost quality and resilience of EU health systems.

Parliament negotiators agreed on a deal with member states to significantly step up the EU’s action in the health sector through a dedicated 5.1 billion EUR "EU4Health Programme" as part of the EU’s recently agreed long-term budget.

The new programme will support actions in areas where the EU's contribution will clearly be valuable, invest in health promotion and disease prevention measures and prepare European health systems to face future health threats.

Addressing cross-border health threats

Supporting member states in developing quality healthcare standards at national level will be one of the programme’s specific objectives. By making health systems more resilient, EU4Health will prepare the EU more thoroughly for major cross-border health threats. This should enable the EU to face not only future epidemics, but also long-term challenges such as an ageing population and health inequalities.

The new European Health Emergency Preparedness and Response Authority will be created to support a better EU-level response to cross-border health threats. It will also be eligible for funding through EU4Health.

As a well-informed public is vital in preventing and responding to diseases, the programme also supports communication activities to promote disease prevention and a healthy lifestyle and to counter misinformation.

Better availability of affordable medicines and medical devices

The COVID-19 crisis has highlighted many weaknesses in national health systems including their dependence on non-EU countries to supply medicines, medical devices as well as personal protective equipment. The programme will therefore support actions, which foster the production, procurement and management of such crisis-relevant products in the EU in order to make them more available and affordable. Actions to develop medicinal products and medical devices that are less harmful for the environment are also eligible.

20 % of the total budget shall be reserved for health promotion and disease prevention by addressing health risks such as the harmful use of alcohol and tobacco. Digitalising healthcare, including by supporting the creation of a European health data space, is also part of the deal.

Supporting actions to promote access to quality healthcare, including access to sexual and reproductive healthcare and the EU’s fight against cancer is also a priority. In addition, it will be possible to support global health initiatives e.g. actions proposed by the WHO.

After the deal, Parliament's rapporteur Cristian-Silviu Buşoi (EPP, RO) said: "The COVID-19 crisis has exposed the need for well-defined and adequately-financed health instruments. We also need to boost innovation and invest more in health in general. It was crucial to increase funding for the EU4Health Programme from €1.7 billion to €5.1 billion in order to be able to deal with future pandemics and health threats, and to make our health systems more resilient. I am also happy that this deal will contribute to the establishment of a reserve of health crisis relevant products, such as essential medicines, vaccines and medical devices."

Next steps

The provisional deal still needs to be approved by Parliament as a whole as well as Council.

Background

The Commission has put forward a new stand-alone EU4Health Programme for 2021-2027 as part of the Recovery Plan. The Health Programme was previously under the initial EU long-term budget 2021-2027 as one element of the European Social Fund Plus (ESF+).

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...